T

TAKE LIMITED

TAKE
Market snapshot · 2026-08-11 05:05 UTC

23.00

+₹0.01 (+0.04%)

MARKET CAP

₹336.32 Cr

STOCK P/E

79.3x

52W HIGH

₹50.14

52W LOW

₹8.90

BOOK VALUE

₹2.06

EPS

₹0.29

ROE

16.52%

SECTOR

Healthcare

DEBT/EQUITY

VOLUME

1.36L

P/B RATIO

11.15x

PEG RATIO

Sector

Healthcare

Themes

Health Information Services
₹49.16₹39.25₹29.35₹19.45₹9.54VolumeAug '25Sep '25Nov '25Jan '26Mar '26Apr '26Jun '26Aug '26

AI Summary

✦ Clartha

Valuation Metrics

Trading 10.3% above historical median. Valuation is rising — currently in the undervalued zone (z-score: +0.1). Confidence: 54%.

Live forward EPS implies next-12-month EPS of ₹18.02. Applying the stock's normalized valuation corridor produces a fair range of ₹1,003.89 to ₹1,687.75, with base value near ₹1,295.28 (+5531.7% vs current price).

Forward Valuation Outlook

Live forward estimate anchored to the company's historical valuation corridor.

Below normalized range

Forward EPS

₹18.02

Forward P/E

1.3x

Base Fair Value

₹1,295.28

Fair Range

₹1,003.89 - ₹1,687.75

Upside To Base

+5531.7%

Estimate Source

Live forward EPS

P/E
Undervalued

5Y Average

82.59

Current

79.31

Overvalued

93.66

Undervalued

55.71

P/S
Undervalued

5Y Average

6.46

Current

6.21

Overvalued

7.74

Undervalued

4.68

P/B
Strongly Undervalued

5Y Average

15.42

Current

11.15

Overvalued

22.08

Undervalued

7.14

Peers & Comparison

Sector: Healthcare

No peer data available for this company.
WHY THESE PEERS

Peers are filtered to companies with market cap between 0.2x and 5.0x of the primary company.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹54 CrMar 2026

Latest net profit

₹4.00 CrMar 2026

Latest EPS

₹0.29Mar 2026

Net margin

-1.5%Mar 2026

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26-4.0%-3.0%-2.0%-1.0%0.0%-20 Cr0.00 Cr20 Cr40 Cr60 Cr
  • Revenue
  • Net income
  • Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.00 Cr15 Cr30 Cr45 Cr60 Cr₹-0₹-0₹0₹0₹0
  • Revenue
  • EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
RevenueExpensesDepreciationOperatingprofitOther incomeInterestProfitbefore taxTax & otherNet Profit-20 Cr0.00 Cr20 Cr40 Cr60 Cr

Latest reported period: Mar 2026

Debt level and coverage

Debt, cash and free cash flow compared on the same crore scale.

Rs crore
Debt free
Mar 2025Mar 2026-20 Cr0.00 Cr20 Cr40 Cr60 Cr
  • Free cash flow
  • Cash & equivalents

Results

Sales

₹54 Cr

Net Profit

₹4 Cr

-90.9%

EBITDA

₹4 Cr

-22.6%

EPS

₹0.29

-91.1%
MetricDec 2024Mar 2025Jun 2025Dec 2025Mar 2026
Sales000054
Expenses311055
Operating Profit-3-1-1-0-1
OPM %-1.52%
Other Income92015
Interest10000
Depreciation00000
Profit before tax50-114
Tax %0.0%0.0%-0.0%0.0%0.0%
Net Profit48-5-114
EPS in Rs3.26-0.33-0.060.070.29

All values in ₹ Crores unless otherwise stated. Source: Company filings.

Shareholding Pattern

HolderMar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters53.41%53.34%5.19%
FII0.56%0.28%
Public40.44%40.49%40.40%38.80%31.60%
Others6.15%6.17%54.41%60.64%68.12%
Mar 2026
FII
Public
Others